CasNo.3081-61-6,L-Theanine,(3081-61-6) Suppliers

0 Metric Ton	Negotiable

Min.Order :0 Metric Ton
Purity: 98%

Keywords

Biochemistry Biological pharmaceutical Pharmaceutical intermediates

Quick Details

Appearance:White to Off White Powder
Application:
PackAge:
ProductionCapacity:|Metric Ton|Day
Storage:
Transportation:

Superiority:

Product ID：TQAA017
Product Name：L-Theanine
CAS NO:3081-61-6
Molecular Formula：C7H14N2O3
Molecular Weight：174.2
Purity：≥98%
Grade：Pharmaceutical Grade
Appearance：White to Off White Powder
Application：L-Theanine modulates the activity of several antitumor drugs and has been reported to stimulate self-renewal of human embryonic stem cells. L-Theanine binds to AMPA, Kainate, NMDA, and group I mGlu receptors.

Theanine is able to bind to AMPA, kainite, and NMDA glycine receptors in rat cortical neurons but with less affinity than glutamic acid. It has been studied as a glutamate transport inhibitor, preventing glutamate uptake by M5076 ovarian sarcoma-bearing mouse cells and increasing the effect of doxorubicin on tumor growth in M5076 mice.
Storage Conditions：2-8°C

Details:

Product ID：TQAA017
Product Name：L-Theanine
CAS NO:3081-61-6
Molecular Formula：C7H14N2O3
Molecular Weight：174.2
Purity：≥98%
Grade：Pharmaceutical Grade
Appearance：White to Off White Powder
Application：L-Theanine modulates the activity of several antitumor drugs and has been reported to stimulate self-renewal of human embryonic stem cells. L-Theanine binds to AMPA, Kainate, NMDA, and group I mGlu receptors.

Theanine is able to bind to AMPA, kainite, and NMDA glycine receptors in rat cortical neurons but with less affinity than glutamic acid. It has been studied as a glutamate transport inhibitor, preventing glutamate uptake by M5076 ovarian sarcoma-bearing mouse cells and increasing the effect of doxorubicin on tumor growth in M5076 mice.
Storage Conditions：2-8°C